Cue Biopharma stock rallies nearly 40% on upcoming presentations Oct. 04, 2024 3:39 PM ET By: Val Brickates Kennedy , SA News Editor [Seeking Alpha]
Cue Biopharma, Inc. (CUE)
US:NASDAQ Investor Relations:
cuebiopharma.gcs-web.com/news-releases
Company Research
Source: Seeking Alpha
presentations for its Immuno-STAT drug candidates CUE-101 and CUE-102 at an upcoming medical meeting. The biotech company said it will present data from a Phase 1 study of CUE-101 in the treatment of recurrent/metastatic HPV16+ head and neck squamous cell cancer. It also plans to present data from a Phase 1 study of CUE-102 in certain patients with WT1-positive recurrent/metastatic cancers. Cue ( CUE ) will make the presentations at the Society for Immunotherapy of Cancer's 39 th Annual Meeting, which will be held in Houston, Texas, from Nov. 6 to Nov. 10, according to a statement More on Cue Biopharma Cue Biopharma, Inc. (CUE) Q2 2024 Earnings Call Transcript Cue Biopharma, Inc. 2024 Q2 - Results - Earnings Call Presentation Cue Biopharma prices $12M stock offering Cue biopharma announces proposed public offering Seeking Alpha's Quant Rating on Cue Biopharma Recommended For You Comments More Trending News Recommended For You More Trending News
Show less
Read more
Impact Snapshot
Event Time:
CUE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CUE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CUE alerts
High impacting Cue Biopharma, Inc. news events
Weekly update
A roundup of the hottest topics
CUE
News
- Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]Yahoo! Finance
- Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- Cue Biopharma to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare ConferenceGlobeNewswire
CUE
Earnings
- 11/14/24 - Beat
CUE
Sec Filings
- 2/14/25 - Form SCHEDULE
- 1/3/25 - Form 4
- 1/3/25 - Form 4
- CUE's page on the SEC website